The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials ...
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...
Scientists have engineered a never-before-seen quantum state, uncovering a new phase of matter with hidden order beyond conventional theory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results